SCHEMBL27769009

SCHEMBL27769009

Fc1cc(OC(F)F)ccc1-n1cccn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 1/20 0.40
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 2/20 0.40
MAPT P10636 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
G6PD P11413 1/20 0.40
ACLY P53396 1/20 0.39
KCNH2 Q12809 5/20 0.37
CYP2C8 P10632 1/20 0.37
CYP2C9 P11712 1/20 0.37
KCNN4 O15554 1/20 0.37
KCNA5 P22460 1/20 0.37
NPC1 O15118 1/20 0.36
MAPK1 P28482 1/20 0.36
F2RL1 P55085 1/20 0.36
ADRA1A P35348 1/20 0.36
TDO2 P48775 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16711902 0.80 KCNH2 (0.43) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL28071287 0.77 RXRA (0.49) ALDH1A1KDM4ELMNANPC1MAPK1
SCHEMBL16712132 0.77 KCNH2 (0.39) ALDH1A1MEN1MAPTKMT2AACLY
SCHEMBL4302034 0.76 KCNN4 (0.52) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL30038214 0.76 KCNN4 (0.52) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL24214955 0.73 MAPT (0.46) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL7031585 0.73 ALDH1A1 (0.46) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL31710093 0.73 ALDH1A1 (0.55) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL7031591 0.73 ALDH1A1 (0.46) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL30719692 0.73 NOTUM (0.53) ALDH1A1MEN1MAPTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101420941-A Use of GPR119 receptor agonists for increasing bone mass and for treating osteoporosis, and related combination therapies ARENA PHARM INC (US) 2009-04-29 CN disclosed